+467.0%
MRNA vs ILMN
+115.7%
+351.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ILMN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.6% | +2.8% | +2.8% |
| 7D | -1.1% | -5.4% | +4.3% | +4.6% |
| 30D | +126.1% | +7.0% | +119.1% | +113.8% |
| 3M | +190.0% | +24.2% | +165.8% | +157.8% |
| 6M | +157.2% | +69.9% | +87.3% | +101.1% |
| YTD | +388.2% | +57.4% | +330.8% | +297.3% |
| 1Y | +467.0% | +107.9% | +359.1% | +335.2% |
| All | +467.0% | +115.7% | +351.3% | +335.2% |
Cumulative growth
Daily Returns
Daily percentage return beside ILMN.
Daily Out/Under-Performance
Portfolio return minus ILMN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ILMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ILMN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling